Cell Line Development Market Analysis by (Reagents & Media, Equipment), by Source (Mammalian, Non-Mammalian), by Type (Recombinant, Hybridomas, Continuous Cell Lines), by Application (Bioproduction, Drug Discovery, Toxicity Testing) and by Region – Forecast to 2026
- Additional information
- Enquire about
Cell Line Development Market Analysis by (Reagents & Media, Equipment), by Source (Mammalian, Non-Mammalian), by Type (Recombinant, Hybridomas, Continuous Cell Lines), by Application (Bioproduction, Drug Discovery, Toxicity Testing) and by Region - Forecast to 2026
The global Cell Line development market size is expected to witness a CAGR of X.X% during the forecast period. Increasing prevalence of chronic diseases such as cancer, rising investment in the vaccine development, and mounting demand for biologics & biosimilars are some of the major factors boosting the global market. Also, escalating demand for regenerative medicines in developed as well as developing countries is projected to drive the market growth. However, stringent government regulations and ethical issues associated with the use of animal source are hindering the market growth.
Key players in the cell line development market are Corning, Inc. (U.S.); American Type Culture Collection (ATCC) (U.S.); European Collection of Cell Cultures (ECACC) (U.K.); Thermo Fisher Scientific, Inc. (U.S.); Sigma Aldrich Corporation (U.S.); Lonza Group AG (Switzerland); Selexis SA (Switzerland); Wuxi App Tec, Inc. (China); GE Healthcare (U.K.) and Sartorious AG (Germany). The leading players operating in the cell line development industry are adopting various strategies including collaborations, mergers & acquisitions, regional expansions, and new product launches.
This exhaustive research report focuses on market size and forecast at global, segmental, regional and country level along with key market trends and dynamics from 2017 to 2026. The cell line development market report is categorized into the following segments and subsegments:
Cell Line Development Market, By Product (Revenue, 2017-2026, USD Million)
- Reagents and Media
- Storage Equipment
Cell Line Development Market, By Source (Revenue, 2017-2026, USD Million)
- Mammalian Cell Line
- Non-Mammalian Cell Line
Cell Line Development Market, By Type (Revenue, 2017-2026, USD Million)
- Recombinant Cell Lines
- Primary Cell Lines
- Continuous Cell Lines
Cell Line Development Market, By Application (Revenue, 2017-2026, USD Million)
- Toxicity Testing
- Tissue Engineering
- Drug Discovery
Cell Line Development Market, By Region (Revenue, 2017-2026, USD Million)
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of APAC
- Latin America
- Rest of LATAM
- Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of MEA
Key questions addressed by the research report-
- What are the current market trends (2017 to 2020) and future market forecast from 2021 to 2026 for the market?
- What are the market dynamics and probable opportunities for market players during the forecast period?
- Initiatives undertaken my market players to address the COVID-19 impact to sustain in the competitive market.
- Which geographies have immense opportunities in different segments and sub-segments of the market?
- What are the recent strategies adopted by market players such as product launch, partnership, agreement, collaboration, merger & acquisition, and geographical expansion?